Katharine Jarmul keynotes on common myths around privacy and security in AI and explores what the realities are, covering design patterns that help build more secure, more private AI systems.
Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results